Global Genital Herpes Treatment Market

$2,600.00

产品代码: GH02385R 行业: 地区:

Genital herpes is a common sexually transmitted infection caused by the herpes simplex virus (HSV). It causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. Two types of the herpes simplex virus (HSV) cause genital herpes: HSV-1 and HSV-2. The World Health Organization stated that in 2016, about 3.7 billion people under age 50 years had contracted HSV-1. In the same year, around 491 million people ages 15 到 49 years had an HSV-2 infection. 根据Gen Consulting公司最新分析, the global genital herpes treatment market was USD 2,045 百万 2021 预计将达到美元 2,709 百万 2028 复合年增长率为 4.1% 在预测期内, 2022-2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global genital herpes treatment market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the genital herpes treatment industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, virus type, 给药途径, 分销渠道, 和地区. The global market for genital herpes treatment can be segmented by product: acyclovir, famciclovir, valacyclovir, 其他的. The acyclovir segment was the largest contributor to the global genital herpes treatment market in 2021. Genital herpes treatment market is further segmented by virus type: HSV-1, HSV-2. 根据给药途径, the genital herpes treatment market is segmented into: 注射, 口服, topical. The oral segment held the largest revenue share in 2021. 以分销渠道为基础, the genital herpes treatment market also can be divided into: 医院, 网上药店, 药房 & 药店. Genital herpes treatment market by region is categorized into: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

副产品:
acyclovir
famciclovir
valacyclovir
– 其他的

By virus type:
HSV-1
HSV-2

按给药途径:
– 注射
– 口服
topical

按分销渠道:
– 医院
– 网上药店
– 药房 & 药店

按地区:
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (排)

The report explores the recent developments and profiles of key vendors in the Global Genital Herpes Treatment Market, 包括雅培实验室, Avet Pharmaceuticals Inc., Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, 葛兰素史克公司, 诺华公司, 辉瑞公司, 梯瓦制药工业有限公司, 维亚特里斯公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global genital herpes treatment market.
To classify and forecast the global genital herpes treatment market based on product, virus type, 给药途径, 分销渠道, 地区.
To identify drivers and challenges for the global genital herpes treatment market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global genital herpes treatment market.
To identify and analyze the profile of leading players operating in the global genital herpes treatment market.

为什么选择这份报告
Gain a reliable outlook of the global genital herpes treatment market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Genital Herpes Treatment Market

对这份报告感兴趣? 立即获取免费样品!
Global Genital Herpes Treatment Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

4.1%

页数

88

行业参与者

雅培实验室, Avet Pharmaceuticals Inc., Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, Glenmark Pharmaceuticals Limited, 葛兰素史克公司, 诺华公司, 辉瑞公司, 梯瓦制药工业有限公司, 维亚特里斯公司.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Genital Herpes Treatment Market

请填写我们的表格,我们会尽快回复您.